Oriola Oyj represents a set of core values and a strong corporate philosophy. They believe in delivering customer value by providing high-quality services and products. Oriola Oyj focuses on building long-term partnerships, trust, and reliability with their stakeholders. They prioritize innovation, excellence, and continuous improvement to meet the changing needs of their customers. Moreover, integrity, transparency, and ethical business practices are key elements of Oriola Oyj's corporate philosophy. Through their committed team and customer-centric approach, Oriola Oyj aims to create sustainable growth and contribute to the well-being of society.

Oriola Oyj is primarily present in the Nordic and Baltic regions.

Oriola Oyj, a leading healthcare and pharmaceutical company, has accomplished several significant milestones in its history. The company successfully expanded its operations into new regions, establishing a strong presence in the Nordic and Baltic countries. Oriola Oyj has cultivated valuable partnerships with renowned pharmaceutical manufacturers and healthcare providers, strengthening its position in the market. The company has consistently embraced technological advancements and innovative solutions, enhancing its efficiency and effectiveness in the healthcare industry. Additionally, Oriola Oyj has demonstrated remarkable growth and financial stability, further solidifying its reputation as a reliable and trusted healthcare partner.

Oriola Oyj is a Finnish company with a rich history and background. Founded in 2006, Oriola is a leading service and wholesale company in the pharmaceutical and healthcare sectors in Sweden and Finland. The company has a strong presence in the Nordic and Baltic markets, offering a wide range of services including pharmaceutical distribution, retail pharmacy operations, and support services for healthcare professionals. With a focus on providing people with access to safe and effective healthcare products and services, Oriola has established itself as a trusted and reliable partner in the industry. Today, Oriola continues to grow and innovate, driving the development of the healthcare sector in the Nordic region.

The main competitors of Oriola Oyj in the market include companies such as Tamro, McKesson, and Apotek Hjärtat.

Oriola Oyj is primarily active in the pharmaceutical and healthcare industries.

Oriola Oyj, a leading Finnish company, operates in the field of healthcare and pharmaceutical services. Its robust business model centers around two main areas: Pharmaceutical Trade and Services. Oriola provides comprehensive pharmaceutical distribution and wholesale services, ensuring the delivery of medicinal products to pharmacies, hospitals, and other healthcare professionals. Additionally, the company offers efficient retail and e-commerce services through its own chains of pharmacies, providing expert advice and a wide range of healthcare products to customers. Oriola Oyj's business model embraces the entire pharmaceutical value chain, enabling it to deliver essential healthcare solutions effectively and sustainably.

KGV za Oriola Oyj trenutno ne može biti izračunato.

KUV za Oriola Oyj trenutno ne može biti izračunat.

AlleAktien kvalitativni skor za Oriola Oyj je 3/10.

očekivana Oriola Oyj promet je 1,87 milijardi EUR.

Dobit očekivana Oriola Oyj je 14,20 mil. EUR.

Oriola Oyj is a Finnish company that operates in the healthcare industry and offers services in the areas of pharmaceuticals, healthcare products, and animal health. The company was founded in 1901 and is headquartered in Espoo, Finland. The company is divided into three main business areas: Pharmaceuticals, healthcare products, and animal health. In the pharmaceuticals sector, Oriola Oyj provides logistics and trading services to independent, professional customers in the healthcare industry. The company operates a large distribution center in Vantaa, Finland, which delivers drugs to customers in Finland, Sweden, and Norway. It is also able to develop customized solutions for customers based on their specific needs. In the healthcare products sector, Oriola Oyj offers a wide range of products and services that focus on people's well-being. These include dietary supplements, vitamins, minerals, herbal products, and cosmetics. These products are sold in Finland, Sweden, Norway, Denmark, Estonia, Latvia, and Lithuania. Oriola Oyj also collaborates with leading manufacturers such as Pfizer, Roche, MSD, and Sanofi to distribute their healthcare products in the Nordic countries. In the animal health sector, Oriola Oyj also offers a wide range of products and services. These include veterinarians, animal clinics, pet stores, and animal breeding companies in Finland, Sweden, and Norway. The product range includes animal medicines, healthcare products, feed supplements, and diet products for animals. Oriola Oyj works with renowned animal medicine manufacturers such as MSD Animal Health, Elanco, Boehringer Ingelheim, and Zoetis. An essential element of Oriola Oyj's business model is its focus on quality and safety. The company is committed to complying with national and international regulations and standards and implements strict quality control processes to ensure the integrity of the drug supply chain and the safety of consumers. Oriola Oyj also operates in accordance with Good Distribution Practice (GDP), an international standard for the cannabis industry that ensures products are stored, delivered, and received in a controlled environment. Overall, Oriola Oyj is a leading company in the healthcare industry that offers its customers high-quality products and services. With its strong presence in Scandinavia and close relationships with leading manufacturers worldwide, the company is well-positioned to grow and meet the market's needs in the future.

Oriola Oyj isplaćuje dividendu od 0,04 EUR raspoređenu preko isplata u toku godine.

Dividenda za Oriola Oyj trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Oriola Oyj je FI0009014351.

WKN od Oriola Oyj je A0J3P9.

Oznaka za praćenje akcija kompanije Oriola Oyj je ORIOLA.HE.

U poslednjih 12 meseci, Oriola Oyj je isplatio dividendu u iznosu od 0,07 EUR . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Oriola Oyj će verovatno isplatiti dividendu od 0,07 EUR.

Dividendski prinos od Oriola Oyj trenutno iznosi .

Oriola Oyj isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima април, април, април, мај.

Oriola Oyj je isplaćivao dividendu svake godine u poslednjih 13 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0,07 EUR. To odgovara dividendnom prinosu od 6,71 %.

Oriola Oyj se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Oriola Oyj od 15. 4. 2025. u iznosu od 0,07 EUR, morali ste da imate akciju u depou pre Ex-dana 3. 4. 2025..

Isplata poslednje dividende izvršena je 15. 4. 2025..

U godini 2024 kompanija Oriola Oyj je isplatila 0,06 EUR kao dividende.

Dividende od Oriola Oyj se isplaćuju u EUR.